Several advances in kidney cancer have occurred over the past decade, including the discovery of mutations in chromatin remodelling genes and genomic heterogeneity in clear cell renal cell carcinoma (ccRCC). Altered metabolic patterns in ccRCC and papillary RCC have become apparent, and new drugs for ccRCC have been approved.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding
Nature Communications Open Access 29 June 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Jonasch, E. & Motzer, R. J. Ten years of progress in renal cell carcinoma. J. Natl Compr. Canc. Netw. 10, 690–693 (2012).
Dalgliesh, G. L. et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 463, 360–363 (2010).
Varela, I. et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 469, 539–542 (2011).
The Cancer Genome Atlas Research Network. Comprehensive Molecular Characterization of Clear Cell Renal Cell Carcinoma. Nature 499, 43–49 (2013).
Metallo, C. M. et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481, 380–384 (2011).
Mullen, A. R. et al. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481, 385–388 (2011).
Gerlinger, M. et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat. Genet. 46, 225–233 (2014).
Tong, W. H. et al. The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels. Cancer Cell 20, 315–327 (2011).
Adam, J. et al. Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell 20, 524–537 (2011).
Ooi, A. et al. An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell 20, 511–523 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Linehan, W., Ricketts, C. Discoveries, therapies and opportunities. Nat Rev Urol 11, 614–616 (2014). https://doi.org/10.1038/nrurol.2014.262
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2014.262
This article is cited by
-
P4HA3 promotes clear cell renal cell carcinoma progression via the PI3K/AKT/GSK3β pathway
Medical Oncology (2023)
-
The Role of DNA Methylation in Renal Cell Carcinoma
Molecular Diagnosis & Therapy (2018)
-
High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatment
Modern Pathology (2016)
-
The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding
Nature Communications (2016)
